<- Go home

Added to YB: 2017-09-25

Pitch date: 2017-09-25

ANTH:US [bullish]

Anthera Pharmaceuticals, Inc.

-99.99%

current return

Author Info

No bio for this author

Company Info

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.

Market Cap

$26.00

Pitch Price

$1.68

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

0.00

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
ANTHERA PHARMACEUTICALS INC COM ANTH:US

A summary for this pitch has not been created yet.

Read full article (0 min)